comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 15:27:59 - browse：62697

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： The struggle to figure out which patients 'deserve' Wegovy

explore

WSS

The struggle to figure out which patients 'deserve' Wegovy

6 solutions to address cancer drug shortages and others

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Covid’s new normal has set in amid another rise in cases

6 solutions to address cancer drug shortages and others

Study points to new risk in gene therapy death of Terry Horgan

knowledge

comprehensive

Wikipedia

New air purifier tech could be key to improving indoor air quality

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Supreme Court strikes down use of affirmative action

WHO recommends second malaria vaccine

United colonoscopy coverage change 'may cost lives,' doctors say

Senate bill would ban some hospital facility fees

Drug repurposing or repositioning? The language matters

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Hepatitis C has a cure — but many Americans still lack access to it

Setback for rare diseases as Taysha Gene Therapies pulls back

hotspot

Study points to new risk in gene therapy death of Terry Horgan

Neurocrine congenital adrenal hyperplasia trial succeeds

Some top drug companies are starting to take action on climate

The stability of $0 premiums in Medicare Advantage

Assistant physicians can help address the primary care shortage

'A game

focus

hotspot

explore

focus